Dr. Deborah K. VanderVeen, MD, is a Professor of Ophthalmology at Harvard Medical School and an international leader in pediatric cataract surgery and retinopathy of prematurity (ROP). As Director of the Pediatric Cataract Service at Boston Children’s Hospital, she is nationally recognized for her expertise in managing complex pediatric cataracts and advancing the use of intraocular lenses in infants and young children. She is Director of the ROP service and pioneered the telemedicine program, which was among the first in the United States and currently provides remote ROP screening for infants in several New England states. 

An accomplished clinician-scientist, Dr. VanderVeen has co-led numerous NIH-sponsored clinical trials, including the Infant Aphakia Treatment Study, which set the standard of care for infants with unilateral cataract. Over her 25+ year tenure at Boston Children’s Hospital, she has trained future leaders in pediatric ophthalmology, organized educational workshops, and delivered prestigious invited and names lectures. Her dedication to clinical care, teaching, and research has earned her numerous honors, including Senior Achievement Awards from the American Academy of Ophthalmology and the American Association for Pediatric Ophthalmology and Strabismus, as well as election to the American Ophthalmological Society.

Financial disclosure: Dr. Vanderveen has/had an affiliation (financial or otherwise) with a commercial organization:

• OPhtec Inc - Consultant